Skip to main content
. 2021 Nov 8;77(2):443–447. doi: 10.1093/jac/dkab405

Figure 1.

Figure 1.

In vivo efficacy comparison of 48 h control, cefepime HSR and cefepime/taniborbactam HSR against individual (a) Enterobacterales isolates and (b) P. aeruginosa and S. maltophilia isolates. Each bar represents the average bacterial density (±SD) of 12 infected kidneys from six mice. An asterisk indicates a statistically significant decrease in cfu/kidney compared with cefepime HSR. The y-axis starts at the lower limit of detection (2.00 log10 cfu/kidney). This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.